SecBot SecBot
8-K ·Filed Oct 15, 2026

ALXO

ALX ONCOLOGY HOLDINGS INC
MIXED
Impact 6/10
Horizonweeks Processed10d 18h ago SEC0001193125-26-422992
Killer combo: Material agreement + unregistered equity (likely PIPE/convertible)
Actionable Insight ◆ Mixed

The surrender of 13.35M shares reduces the outstanding float, but the issuance of immediately-exercisable pre-funded warrants means the three large holders can re-enter at any time via cashless exercise. Watch for Form 4 filings showing warrant exercise and subsequent open-market sales — the 4.99%/9.99% beneficial ownership blockers limit immediate re-entry but holders can increase the cap after 61 days' notice. The net effect on share count is neutral-to-negative over the medium term as these holders likely monetize their positions.

DirectionMixed
Confidencehigh
Horizonweeks
Latest settled — T+5d
ALXO ▲ +10.38% at T+5d
NEUTRAL call +10.38% · α vs SPY +10.81% · entry $1.06 → $1.17
Next anchor: T+20d in 17d
Entry = T+0 close
Oct 15, 2026
via day close
T+1d
+7.55%
call +7.55% · α +7.12%
$1.14
settled 10d ago
T+5d
+10.38%
call +10.38% · α +10.81%
$1.17
settled 4d ago
T+20d
Pending
in 17d
T+60d
Pending
in 3mo

Price Chart

Loading chart...

Executive Summary

ALX Oncology entered into exchange agreements with major stockholders (Blackstone, RA Capital, venBio) to surrender 13,353,384 shares of common stock for no consideration in exchange for pre-funded warrants exercisable at $0.001 per share. The transaction, structured as an exempt exchange under Section 3(a)(9) of the Securities Act, eliminates the overhang from these large holders' existing common stock positions while granting them deeply in-the-money warrants that can be exercised immediately via cashless exercise. This is a balance-sheet restructuring that reduces share count but creates immediate potential for re-dilution at the holders' discretion.

Key Facts

  • Stockholders surrendered 13,353,384 shares of common stock for no consideration
  • Company issued pre-funded warrants to purchase 13,353,384 shares at $0.001 per share
  • Participants: Blackstone Annex Master Fund (12,885,891 shares), RA Capital Healthcare Fund (213,667 shares), venBio Global Strategic Fund (253,826 shares)
  • Warrants exercisable immediately via cashless exercise, never expire until exercised in full
  • Exchange structured under Section 3(a)(9) of the Securities Act — no registration required
  • Settlement expected on October 15, 2026

Financial Impact

13,353,384 shares retired from outstanding count; 13,353,384 pre-funded warrants issued with $0.001 exercise price — warrants represent essentially immediate re-dilution at holder's option via cashless exercise

dilutionshare countcapital structure

Risk Factors

  • Pre-funded warrants allow immediate re-dilution via cashless exercise at holders' discretion
  • Blackstone (12.9M shares) is the dominant participant — its exit strategy post-exchange will determine float impact
  • No cash proceeds to the company — this is purely a capital structure reshuffling, not a capital raise
  • Warrants have no expiration — overhang persists indefinitely until exercised

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001193125-26-422992
Document: alxo-ex10_1.htm0001193125-26-422992
Document: alxo-20261014.htm0001193125-26-422992
Document: 0001193125-26-422992-index-headers.html0001193125-26-422992
Document: 0001193125-26-422992-index.html0001193125-26-422992
Document: 0001193125-26-422992.txt0001193125-26-422992
15 reports for ALXO
Performance horizon
100% Hit rate @ T+5 3 of 3 directional calls Went positive at some point 3 of 3 best @ T+20▲ +25.96%May 8, 2026
Filters
Rows
Reports for ALXO — sortable, filterable
TypeNow
Oct 16, 2026
9d ago
SC 13D/A
NEUTRAL ★ 4/10
$1.14awaiting T+5—$1.12 (−2.19%)
Oct 15, 2026
10d ago
8-K
MIXED ★ 6/10
$1.06 $1.17▲ +10.38%▲ +10.81%$1.12 (+5.19%)
Sep 28, 2026
28d ago
Press Release
MIXED ★ 5/10
$1.39 $1.21▼ −12.95%▼ −14.15%$1.12 (−19.78%)
Aug 15, 2026
10w ago
Institutional Cluster
NEUTRAL ★ 4/10
$1.97 $1.99▲ +1.02%▲ +2.21%$1.12 (−43.40%)
Aug 6, 2026
11w ago
8-K
NEUTRAL ★ 4/10
$2.11 $1.94▼ −8.06%▼ −9.27%$1.12 (−47.16%)
Jun 30, 2026
16w ago
8-K
NEUTRAL ★ 3/10
$2.06 $2.36▲ +14.56%▲ +14.30%$1.12 (−45.87%)
Jun 26, 2026
17w ago
8-K
NEUTRAL ★ 5/10
$2.20 $2.19▼ −0.45%▼ −1.84%$1.12 (−49.32%)
Jun 12, 2026
19w ago
Institutional Cluster
BEARISH ★ 5/10
$1.58 $1.53▲ +3.16%▲ +3.84%$1.12 (+29.43%)
May 8, 2026
24w ago
8-K
NEUTRAL ★ 5/10
$2.08 $2.04▼ −1.92%▼ −3.39%$1.12 (−46.39%)
May 8, 2026
24w ago
Press Release
BEARISH ★ 6/10
$2.08 $2.04▲ +1.92%▲ +3.39%$1.12 (+46.39%)
Showing 10 of 15

US Market Status

Market Open — Closes in 4h 56m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 15, 2026